BALAXI PHARMACEUTICALS
Back to Income Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹52 Cr | ₹48 Cr | ₹37 Cr | ₹6.13 Cr | ₹197 Cr |
What is the latest Consolidated Net Profit of BALAXI PHARMACEUTICALS ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹52 Cr |
Mar2023 | ₹48 Cr |
Mar2022 | ₹37 Cr |
Mar2021 | ₹6.13 Cr |
Mar2020 | ₹197 Cr |
How is Consolidated Net Profit of BALAXI PHARMACEUTICALS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹52 Cr | 7.39 | |
Mar2023 | ₹48 Cr | 29.41 | |
Mar2022 | ₹37 Cr | 507.51 | |
Mar2021 | ₹6.13 Cr | -96.88 | |
Mar2020 | ₹197 Cr | - |
Compare Consolidated Net Profit of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹322.2 Cr | -6.7% | -13.4% | -45.9% | Stock Analytics | |
ADANI ENTERPRISES | ₹271,382.0 Cr | 1% | 4.4% | -18.9% | Stock Analytics | |
REDINGTON | ₹19,192.6 Cr | 9.7% | 7.7% | 8.8% | Stock Analytics | |
MMTC | ₹8,725.5 Cr | 15.2% | 15.1% | -21.2% | Stock Analytics | |
HONASA CONSUMER | ₹7,537.8 Cr | 1.8% | 6.9% | -38.9% | Stock Analytics | |
LLOYDS ENTERPRISES | ₹6,760.1 Cr | 4.3% | 28.4% | 73.9% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -6.7% |
-13.4% |
-45.9% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses